Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00529841 · ClinicalTrials.gov registry record · NA
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
A NA study of Adrenal Hyperplasia, Congenital, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00529841: Completed NA study of Adrenal Hyperplasia, Congenital, sponsored by Baylor College of Medicine.
NCT00529841 is a NA study of Adrenal Hyperplasia, Congenital that has completed, run by Baylor College of Medicine. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00529841, a NA study of Adrenal Hyperplasia, Congenital, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a more physiological approach to the management of children and adolescents with salt wasting Congenital Adrenal Hyperplasia. We will administer the glucocorticosteroid via insulin infusion pump to see whether this treatment will improve the serum hormone concentrations.
Conditions Studied
Interventions
- DRUG Hydrocortisone sodium acetate
Study Locations (1)
Texas
- BCM, Texas Children's Hospital Clinic and General Clinical Research Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00529841 record still lists
NCT00529841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Adrenal Hyperplasia, Congenital appearing as the primary indexed condition, and to 1 intervention - of which Hydrocortisone sodium acetate is the first listed.
NCT00529841 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00529841 about?
NCT00529841 is a clinical study titled "Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia". The purpose of this study is to develop a more physiological approach to the management of children and adolescents with salt wasting Congenital Adrenal Hyperplasia. We will administer the glucocorticosteroid via insulin infusion pump to see whether this treatment will improve the serum hormone con...
What is the current status of trial NCT00529841?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2007-01. Estimated completion is 2008-09.
What conditions does trial NCT00529841 study?
This clinical trial studies the following conditions: Adrenal Hyperplasia, Congenital.
What interventions are being tested in trial NCT00529841?
The interventions under investigation include: Hydrocortisone sodium acetate (DRUG).
Who is sponsoring clinical trial NCT00529841?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00529841 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adrenal Hyperplasia, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00529841's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia